Chemically-Induced Disorders clinical trials

The registry lists 20 studies for Chemically-Induced Disorders across 4 countries. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-08. Counting its 44 narrower conditions too, such as Substance-Related Disorders: 8,596 studies, 1,514 open.

Get an email when these change. Save the Chemically-Induced Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 12
Recruiting: 5
Withdrawn: 1
Active, not recruiting: 1
Terminated: 1

Phase

Phase 1: 4
Phase 2: 3
Phase 3: 2
Phase 4: 1

Where

United States: 16
Spain: 1
Canada: 1
China: 1

Who runs them

University of Maryland, Baltimore (3) · West Virginia University (2) · University of Utah (1) · University of Michigan (1) · Centre for Addiction and Mental Health (1) · NYU Langone Health (1) · University of Virginia (1) · Henrietta Bada (1)

What is being tested here

Drugs under test in Chemically-Induced Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Morphine	1	1	2
Semaglutide	1	0	1
Diclofenac	0	0	1
Suvorexant	0	0	1
Clonidine	0	1	1
Minocycline	0	0	1
Vivitrol	0	0	1
Naltrexone	0	0	1
Psilocybin	0	0	1

Coming up

1phase 3 study under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Apr 2027GLP-1R Agonist Treatment for Opioid Use Disorder · Milton S. Hershey Medical Center

Who these studies take

Of the 5 Chemically-Induced Disorders studies recruiting now, 2 (40%) set no upper age limit and 3 (60%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (20%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	0 (0%)	0 (0%)
18	4 (80%)	4 (80%)
30	4 (80%)	4 (80%)
40	4 (80%)	4 (80%)
50	4 (80%)	4 (80%)
65	4 (80%)	4 (80%)
75	3 (60%)	3 (60%)
85	2 (40%)	2 (40%)

Across all 20 studies, recruiting or not: 70% stop at 75 or younger and 65% at 65; 5% take children; 0% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.